Skinvisible (SKVI) EPS (Basic) Growth (5y) (2015 - 2026)
Powered by 
Analysis
Skinvisible (SKVI) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 648.23 Bn | 627.47 Bn | 17.26 Bn |
| 2 | AbbVie | 443.69 Bn | 437.12 Bn | 12.70 Bn |
| 3 | Merck | 368.29 Bn | 361.15 Bn | 12.21 Bn |
| 4 | Novartis Ag | 270.18 Bn | 262.49 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.93 Bn | 45.55 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.15 Bn | 44.15 Bn | - |
| 8 | Incyte | 25.21 Bn | 20.68 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.11 Bn | 18.44 Bn | 683.80 Mn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.67% |
| Mar 31, 2026 | 12.41% |
| Dec 31, 2025 | 6.11% |
| Sep 30, 2025 | 12.76% |
| Jun 30, 2025 | 5.90% |
| Mar 31, 2025 | 11.44% |
| Dec 31, 2024 | 12.56% |
| Sep 30, 2024 | 15.82% |
| Jun 30, 2024 | 19.48% |
| Mar 31, 2024 | 11.85% |
| Dec 31, 2023 | 12.26% |
| Sep 30, 2023 | -58.62% |
| Jun 30, 2023 | -86.47% |
| Mar 31, 2023 | -152.47% |
| Dec 31, 2022 | -122.31% |
| Sep 30, 2022 | -85.18% |
| Jun 30, 2022 | -54.36% |
| Mar 31, 2022 | -83.87% |
| Dec 31, 2021 | -86.75% |
| Sep 30, 2021 | -61.28% |